Strathdee Steffanie A, Ricketts Erin P, Huettner Steven, Cornelius Lee, Bishai David, Havens Jennifer R, Beilenson Peter, Rapp Charles, Lloyd Jacqueline J, Latkin Carl A
Division of International Health and Cross-Cultural Medicine, Department of Family and Preventive Medicine, University of California-San Diego, 9500 Gilman Drive, Ash Building, Room 118, Mailstop 0622, San Diego, CA 92093, USA.
Drug Alcohol Depend. 2006 Jul 27;83(3):225-32. doi: 10.1016/j.drugalcdep.2005.11.015. Epub 2005 Dec 20.
We evaluated a case management intervention to increase treatment entry among injecting drug users referred from a needle exchange program (NEP). A randomized trial of a strengths based case management (intervention) versus passive referral (control) was conducted among NEP attenders requesting and receiving referrals to subsidized, publicly funded opiate agonist treatment programs in Baltimore, MD. Logistic regression identified predictors of treatment entry within 7 days, confirmed through treatment program records. Of 247 potential subjects, 245 (99%) participated. HIV prevalence was 19%. Overall, 34% entered treatment within 7 days (intervention: 40% versus control: 26%, p=0.03). In a multivariate "intention to treat" model (i.e., ignoring the amount of case management actually received), those randomized to case management were more likely to enter treatment within 7 days. Additional "as treated" analyses revealed that participants who received 30 min or more of case management within 7 days were 33% more likely to enter treatment and the active ingredient of case management activities was provision of transportation. These findings demonstrate the combined value of offering dedicated treatment referrals from NEP, case management and transportation in facilitating entry into drug abuse treatment. Such initiatives could be implemented at more than 140 needle exchange programs currently operating in the United States. These data also support the need for more accessible programs such as mobile or office-based drug abuse treatment.
我们评估了一项病例管理干预措施,以提高从针头交换项目(NEP)转介而来的注射吸毒者的治疗参与率。在马里兰州巴尔的摩市,针对那些请求并接受转介至补贴性、公共资助的阿片类激动剂治疗项目的NEP参与者,开展了一项基于优势的病例管理(干预组)与被动转介(对照组)的随机试验。通过治疗项目记录确认,逻辑回归确定了7天内治疗参与的预测因素。在247名潜在受试者中,245名(99%)参与了研究。艾滋病毒感染率为19%。总体而言,34%的人在7天内开始治疗(干预组:40%,对照组:26%,p=0.03)。在多变量“意向性治疗”模型中(即忽略实际接受的病例管理量),随机分配至病例管理组的人在7天内更有可能开始治疗。额外的“实际治疗”分析显示,在7天内接受30分钟或更长时间病例管理的参与者开始治疗的可能性要高33%,病例管理活动的有效因素是提供交通服务。这些发现表明,从NEP提供专门的治疗转介、病例管理和交通服务,在促进进入药物滥用治疗方面具有综合价值。此类举措可在美国目前运营的140多个针头交换项目中实施。这些数据还支持了对更多可及项目的需求,如流动或基于办公室的药物滥用治疗项目。